Cannabis Suisse Corp. (CSUI) Stock
Cannabis Suisse Corp., based in Bell Gardens, California, specializes in the cultivation, production, and distribution of a diverse range of products. These offerings include recreational tobacco goods, medical CBD oils, and various over-the-counter items such as health-related supplements, face masks, disinfectants, and cigarettes.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Cannabis Suisse Corp.
Cannabis Suisse Corp., based in Bell Gardens, California, specializes in the cultivation, production, and distribution of a diverse range of products. These offerings include recreational tobacco goods, medical CBD oils, and various over-the-counter items such as health-related supplements, face masks, disinfectants, and cigarettes. The company makes its products available to consumers through its dedicated online retail platform, Swiss4Life, as well as via a broader network of retailers. Established in 2016, the firm initially traded as Geant Corp. before officially adopting its current name, Cannabis Suisse Corp., in February 2019.
Cannabis Suisse Corp. is headquartered in US.
Cannabis Suisse Corp. (CSUI) stock trades at $0.01 with a market capitalization of $600788. The stock is valued at a price-to-earnings (P/E) ratio of 5.67, price-to-book of -0.35, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 50.0% below its 52-week high.
On profitability, Cannabis Suisse Corp. generates a return on equity (ROE) of -6.07%, return on capital employed of -132.41%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.cannabissuissecorp.com